The prognostic impact of the metastatic lymph nodes ratio in colorectal cancer by Zhang, C. -H. et al.
ORIGINAL RESEARCH
published: 18 December 2018
doi: 10.3389/fonc.2018.00628
Frontiers in Oncology | www.frontiersin.org 1 December 2018 | Volume 8 | Article 628
Edited by:
Sherif Abdel-Misih,
















†These authors have contributed
equally to this work
Specialty section:
This article was submitted to
Surgical Oncology,
a section of the journal
Frontiers in Oncology
Received: 28 August 2018
Accepted: 03 December 2018
Published: 18 December 2018
Citation:
Zhang C-H, Li Y-Y, Zhang Q-W,
Biondi A, Fico V, Persiani R, Ni X-C
and Luo M (2018) The Prognostic
Impact of the Metastatic Lymph
Nodes Ratio in Colorectal Cancer.
Front. Oncol. 8:628.
doi: 10.3389/fonc.2018.00628
The Prognostic Impact of the
Metastatic Lymph Nodes Ratio in
Colorectal Cancer
Chi-Hao Zhang 1†, Yan-Yan Li 2†, Qing-Wei Zhang 3†, Alberto Biondi 4, Valeria Fico 4,
Roberto Persiani 4, Xiao-Chun Ni 1* and Meng Luo 1*
1Department of General Surgery, Shanghai Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University,
Shanghai, China, 2Department of Radiation Oncology, Shanghai Ninth People’s Hospital, School of Medicine, Shanghai Jiao
Tong University, Shanghai, China, 3Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and
Hepatology, Ministry of Health, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Institute of
Digestive Disease, Shanghai, China, 4Dipartimento Scienze Gastroenterologiche ed Endocrino-Metaboliche, Fondazione
Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
Background: This study was designed to validate the prognostic significance of the ratio
of positive to examined lymph nodes (LNR) in patients with colorectal cancer.
Methods: 218,314 patients from the SEER database and 1,811 patients from the
three independent multicenter were included in this study. The patients were divided
into 5 groups on a basis of previous published LNR: LNR0, patients with no metastatic
lymph nodes; LNR1, patients with the LNR between 0.1 and 0.17; LNR2, patients
with the LNR between 0.18 and 0.41; LNR3, patients with the LNR between 0.42 and
0.69; LNR4, patients with the LNR >0.7. The 5-year OS and CSS rate were estimated
using Kaplan-Meier method and the survival difference was tested using log-rank test.
Multivariate Cox analysis was used to further assess the influence of the LNR on patients’
outcome.
Results: The 5-year OS rate of patients within LNR0 to LNR4 group was 71.2, 55.8,
39.3, 22.6, and 14.6%, respectively (p < 0.001) in the SEER database. While the 5-year
OS rate of those with LNR0 to LNR4 was 75.2, 66.1, 48.0, 34.0, and 17.7%, respectively
(p < 0.001) in the international multicenter cohort. In the multivariate analysis, LNR was
demonstrated to be a strong prognostic factor in patients with <12 and ≥12 metastatic
lymph nodes. Furthermore, the LNR had a similar impact on the patients’ prognosis in
colon cancer and rectal cancer.
Conclusion: The LNR allowed better prognostic stratification than the positive node
(pN) in patients with colorectal cancer and the cut-off values were well validated.
Keywords: Colorectal cancer, lymph node ratio, prognosis, overall survival, SEER database
INTRODUCTION
Colorectal cancer (CRC) is the fourth most common malignancy in America. The estimated
number of cancer-related deaths in 2015 reached 49,190 in 2015 (1). Currently, the TNM
staging system is the most frequently used tool in clinical practice to stage the tumor in CRC
patients and to evaluate their long-term survival outcome. Patients were divided into groups
with different prognosis according to the depth of invasion of primary tumors, the number of
positive lymph nodes (LNs), and the presence of distant metastatic sites. LN status is defined by
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the number of metastatic LNs harvested. Prognosis worsens
when the number of metastatic LNs increases: pN0 (no nodes
involved), pN1 (involved nodes, ≤3) and pN2 (involved nodes,
>3). In addition, the 5-year survival rate of the patients with
stage II colon cancer is approximately 80%. While the rate drops
to 50% in stage III colon cancer patients with LN metastasis.
Therefore, the number of metastatic LNs has been established as
an important prognostic determinant in patients with CRC.
To ensure accurate staging, many studies were carried out
in patients with metastatic CRC to explore the correct number
of LNs that should be examined. However, the results varied
largely among these studies, ranging from as few as 6 to as
many as 40, because the number of examined LNs depends on
the specialty of surgeons, Dukes’ stage, specimen length, tumor
size, individual immune response and skill level of pathology
technicians (2–5). According to recent publications, ratio-based
LN staging emerged as a substitute for the positive LN (pN)
count. In fact, its impact on survival has been proven in some
malignant tumors including pancreatic, gastric, esophageal, and
bladder cancer (6–8). A similar result was also observed among
individuals with CRC (9–11). One of the biggest features of
LNR is that its survival predictive capacity seems less dependent
on the number of resected nodes. Because of this, the LNR
classification may reduce the risk of over- or under-staging in
comparison with traditional pN staging. However, the reported
cut-off values of LNR vary and no consensus has been reached
(12–15). Most of those studies used mean value, quartiles or an
arbitrary classification to calculate ratio-based LN values, and
only three of them used statistical methods.
In a previous study, Rosenberg et al. divided 3,026 patients
into five groups according to the cut-off values of LNR, which
were calculated using the classification and regression trees
method (16). The ratios were 0, 0–0.17, 0.18–0.41, 0.42–0.69,
and >0.7. They demonstrated that these values had the highest
survival impact and stressed its function in the prediction of
the survival of CRC patients as an independent prognostic
factor. The values were also examined by Rosenberg and his
colleagues in another large population from a single medical
center, and the results showed the strong prognostic value of
LNR (17). To further validate the discriminatory performance of
these previously published cut-off values, patients from the SEER
database and three independent cross-international medical
centers were included in this study and were analyzed.
MATERIALS AND METHODS
Surveillance, Epidemiology, and End
Results Database
Data of patients with CRCs from Surveillance, Epidemiology and
End Results (SEER) database was searched and collected through
queries using the latest version of the SEER 18 Regs Research
Data (1973–2014), released in April 2017 with the SEER∗Stat
Abbreviations: LNR, ratio of positive to examined lymph nodes; pN, positive
node; CRC, Colorectal cancer; LN, Lymph node; SEER database, Surveillance,
Epidemiology, and End Results database; CSS, cancer-specific survival; OS, overall
survival; CI, confidence intervals; AIC, Akaike information criterion.
TABLE 1 | Characteristics of patients with colorectal cancer from SEER database
and international multicenter cohort.




Female 114,727(52.5%) 783(43.3%) <0.001
Male 103,614(47.5%) 1,028(56.7%) <0.001
AGE
Mean(95%Cl) 68.1 ± 13.5 67.1 ± 11.5
<60 57,819(26.5%) 475(26.3%) 0.687
≥ 60 160,522(73.5%) 1,336(73.7%) 0.687
TUMOR SIZE (CM)
Mean(95%Cl) 4.7 ± 2.7 4.9 ± 2.2 <0.001
≤ 2 23,232(10.6%) 114(6.3%) <0.001
≤ 3 32,039(14.7%) 262(14.5%) <0.001
≤ 5 76,659(35.1%) 794(43.8%) <0.001
>5 63,165(28.9%) 622(34.3%) <0.001
NA 23,246(10.6%) 9(1.0%) <0.001
TUMOR SITE
Left side 72,103(33.0%) 754(41.6%) <0.001
Right side 108,772(49.8%) 576(31.8%) <0.001
Rectum 34,597(15.8%) 464(25.6%) <0.001
NA 2,869(1.3%) 17(0.9%) <0.001
HISTOLOGY
Adenocarcinoma 192,081(88.0%) 1,630(90.0%) <0.001
Mucinous adenocarcinoma 22,968(10.5%) 178(9.8%) <0.001
Signet ring cell carcinoma 2,001(0.9%) 3(0.2%) <0.001





Poorly or undifferentiated 40,416(18.5%) 1285(71.0%) <0.001
NA 10,029(4.6%) 32(1.8%) <0.001
7th T STAGE
T1 31,045(14.2%) 113(6.2%) <0.001
T2 35,033(16.0%) 219(12.1%) <0.001
T3 124,060(56.8%) 1,211(66.9%) <0.001
T4 28,203(12.9%) 268(14.8%) <0.001
7th M STAGE
M0 20,2131(92.6%) 1,678(92.7%) 0.951
M1 16,210(7.4%) 133(7.3%) 0.951
Total no. of nodes retrieved
[Mean(95%Cl)]
14.2 ± 9.6 10.5 ± 6.4 <0.001
No. of negative nodes (nN)
[Mean(95%Cl)]
12.7 ± 9.5 9.2 ± 6.3 <0.001
No. of positive nodes (pN)
[Mean(95%Cl)]
1.6 ± 3.4 1.3 ± 2.5 0.992
7th N STAGE (7th pN)
N0 135,282(62.0%) 1111(61.3%) 0.008
N1a 24,912(11.4%) 212(11.7%) 0.008
N1b 25,841(11.8%) 250(13.8%) 0.008
N2a 17,399(8.0%) 145(8.0%) 0.008
N2b 14,907(6.8%) 93(5.1%) 0.008
Follow-up(months)
Mean(95%Cl)
82.4 ± 63.0 49.6 ± 30.3 <0.001
CI, confidence interval.
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8.3.5 software. The inclusion criteria for selected patients were as
follows: (1) Patients aged 18 years or older who were diagnosed
between 1988 and 2010; (2) patients with CRC diagnosed as the
only primary cancer without multiple primary cancer elsewhere;
(3) patients with cancer diagnosed microscopically, in whom
surgery for primary cancer and regional LN resection had been
performed with pathological examination of at least one LN;
(4) patients’ whose CRC was defined using the International
Classification of Diseases for Oncology third edition (ICD-O-3)
codes (8,010–8,231 and 8,255–8,576); and (5) patients who
were followed up for at least 2 months were included in the
study. Patients who received chemoradiotherapy at any time or
patients’ whose CRC was not the only primary carcinoma were
excluded (Figure 1).
For SEER database, cancer-specific survival (CSS) was
the primary outcome, while overall survival (OS) and CSS
considering competing death as due to non-CRC death were the
secondary outcomes. Survival time was defined as the time from
diagnosis to the date of death or last contact or November 2016.
FIGURE 1 | Flow chart of patients’ cohort definition from the SEER database.
Since the SEER database includes public-use data, no
institutional review was required. We were allowed to access the
SEER database for research purposes only using the private SEER
ID (Zhang).
International Multicentre Cohort
An independent international multicentre cohort from three
medical centers was used as another validation group using the
same inclusion and exclusion criteria (Supplementary Figure 1).
Patients with histopathologically confirmed CRCwho underwent
colectomy from February 2009 to March 2013 in Shanghai Ninth
People’s Hospital of Shanghai Jiao Tong University and Renji
Hospital of Shanghai Jiao Tong University, and from January
2004 to April 2017 in Catholic University of Rome were selected.
The patients were followed up every 6 months until death or
until the end of the study (30 March 2018) in the two Chinese
hospitals, except for those lost to follow-up. For patients in
the Catholic University of Rome, they were followed up until
death or until end of the study (30 April 2018) except for those
lost to follow-up according to the European Society of Medical
Oncology guidelines.
The study protocol for the international multicentre cohort
was approved by the Institutional Review Board of the Shanghai
Ninth People’s Hospital, Renji Hospital, and the Catholic
University of Rome.
Statistical Analysis
Descriptive statistics were used to examine and report the patient
demographic characteristics. All quantitative variables were
represented as means with 95% confidence intervals (CI). χ2-
test was used to compare the differences of variable distribution
between groups. The end point of our study was OS and CSS.
Survival curves were plotted using the Kaplan-Meier method,
and the difference between curves was compared using the
log rank test. Multivariate analyses were performed with Cox
proportional hazards regression model to evaluate the potential
covariates in relation to 5-year OS and CSS. In addition, we
conducted subgroup analyses according to the tumor location
(colon vs. rectum) and the number of LNs examined with a
prespecified cut-off value of 12. The Akaike information criterion
FIGURE 2 | The correlation between the number of positive lymph nodes and the number of total lymph node harvested in (A) SEER database and (B) international
multicenter cohort.
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(AIC) was used to compare the quality of different statistical
models. The smaller value means a better fit and model for
predicting survival outcome. Besides, the cumulative probability
of CRC-specific death was calculated and multivariate regression
modeling of sub-distribution functions in competing risks were
performed for sensitivity analysis of our findings using the
cmprsk package. All statistical analyses were performed using
SPSS version 13.0 (SPSS, Chicago, IL, United States) and R
software for Windows (version R-3.4.3, the R Foundation for
statistical computing). All statistical comparisons were two-
sided. A P < 0.05 was regarded as a threshold of statistical
significance.
RESULTS
Patient Characteristics From SEER
Database and the International Multicentre
Cohort
According to the inclusion and exclusion criteria, a total of
218,341 patients with CRC were finally selected from the SEER
database, including 103,614 men and 114,727 women. The mean
age of the participants was 68.1 years. The mean number of
retrieved LNs was 14.2. The mean numbers of positive and
negative LNs were 1.6 and 12.7, respectively. According to the 7th
American Joint Committee on Cancer (AJCC) staging system,
the number of patients categorized as pN1 was 50,753, while the
number of those categorized as pN2 was 32,306. The rest of the
patients had no node involvement.
In the multicentre data which included 1,811 patients, 1,330
were diagnosed with colon cancer and 464 had rectal cancer. The
mean number of retrieved LNs was 10.5. The mean numbers of
positive and negative LNs were 1.3 and 9.2, respectively. Their
mean follow-up time was 49.6 months. About 462 patients were
categorized as pN1, and 238 patients were categorized as pN2.
More detailed information can be seen in Table 1.
As shown in Figure 2, the association between positive LNs
and total LNs was plotted based on the data from SEER database
(Figure 2A) and multicentre cohort (Figure 2B). The absolute
number of pN increased as the examined LNs increase.
Distribution of Clinical and Histopathologic
Characteristics Based on Lymph Node
Ratios
In the SEER database, 135,282 patients were classified as LNR0
with 5-year OS and CSS of 71.2 and 84.7%, respectively. A total
of 35,047 patients was classified as LNR1 with 5-year OS and CSS
of 55.8 and 64.2%, respectively. A total of 25,362 patients was
classified as LNR2 with 5-year OS and CSS of 39.3 and 45.9%,
respectively. A total of 13,046 patients was classified as LNR3
with 5-year OS and CSS of 22.6 and 31.2%, respectively. A total
of 9,605 patients was classified as LNR4 with 5-year OS and CSS
of 14.6 and 17.7%, respectively (Table 2).
TABLE 2 | Association between clinicopathologic characteristics and lymph node ratio (LNR) of patients with colorectal cancer in SEER database.
Positive Lymph Node Ratios
Total 0 0.01–0.17 0.18–0.41 0.42–0.69 ≥0.70 P
N Percent N Percent N Percent N Percent N Percent N Percent
pT <0.001
T1 31,045 14.2 28,398 21.0 1,538 4.4 697 2.7 252 1.9 160 1.7
T2 35,033 16.0 28,781 21.3 3,442 9.8 1,818 7.2 666 5.1 326 3.4
T3 124,060 56.8 66,705 49.3 24,559 70.1 17,833 70.3 8,980 68.8 5,983 62.3
T4 28,203 12.9 11,398 8.4 5,507 15.7 5,014 19.8 3,148 24.1 3,136 32.6
pN <0.001
N0 135,282 62.0 135,282 100 0 0 0 0 0 0 0 0
N1a 24,912 11.4 0 0 20,908 59.7 2,917 11.5 552 4.2 535 5.6
N1b 25,841 11.8 0 0 12,031 34.3 10,308 40.6 2,455 18.8 1,047 10.9
N2a 17,399 8.0 0 0 1,929 5.5 9,090 35.8 4,333 33.2 2,047 21.3
N2b 14,907 6.8 0 0 178 0.5 3,047 12.0 5,706 43.7 5,976 62.2
EN 14.2 ± 9.6 13.43 ± 9.46 19.07 ± 10.57 13.87 ± 8.18 12.48 ± 7.76 11.49 ± 8.66 <0.001
PN 1.6 ± 3.4 0 1.67 ± 1.07 3.88 ± 2.48 6.75 ± 4.36 9.88 ± 7.59 <0.001
NN 12.7 ± 9.5 13.43 ± 9.46 17.41 ± 10.08 9.99 ± 6.06 5.73 ± 3.74 1.60 ± 1.86 <0.001
M <0.001
M0 202,131 92.6 132,340 97.8 31,604 90.2 21,294 84.0 10,125 77.6 6,768 70.5
M1 16,210 7.4 2,942 2.2 3,442 9.8 4,068 16.0 2,921 22.4 2,837 29.5
OS 58.3% 71.2% 55.8% 39.3% 22.6% 14.6% <0.001
CSS 68.9% 84.7% 64.2% 45.9% 31.2% 17.7% <0.001
EN, examined nodes; PN, positive nodes; NN, negative nodes; OS, overall survival; CSS, cancer-specific survival.
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In our own collected data, 1,112 patients had no positive LNs,
and the 5-year OS was 75.2%. A total of 232 patients was classified
as LNR1 with a 5-year OS of 66.1%. A total of 246 patients was
classified as LNR2 with a 5-year OS of 48.0%. A total of 132
patients was classified as LNR3 with a 5-year OS of 34.0%. A total
of 89 patients was classified as LNR4 with a 5-year OS of 15.0%
(Supplementary Table 1).
Impact of the pN on OS and CSS in
Patients With Colorectal Cancer
We analyzed the effects of pN on patients’ survival in SEER
database using the multivariate Cox model. As shown in Table 3,
the pN was a strong prognostic factor in predicting patients’
outcome. In addition, gender (P < 0.001), race (P < 0.001),
age (P < 0.001), tumor location (P < 0.001), pathological grade
(P < 0.001), histological type (P < 0.001), T stage (P < 0.001),
and M stage (P < 0.001), as well as tumor size (P < 0.001)
were correlated with the rate of CRC patients’ OS and CSS.
Similarly, our own data also demonstrated that pN was an
independent factor in the prediction of survival of CRC patients
(Supplementary Table 2, P < 0.001).
Impact of the LNR on OS and CSS in
Patients With Colorectal Cancer
As shown in Figure 3, patients in the high LNR group had
poorer OS (Figure 3A, P < 0.001), poorer CSS (Figure 3B,
P < 0.001), and higher cumulative probability of cancer-specific
death (Figure 3C, P < 0.001) than those in relatively low LNR
group. In multivariate Cox analysis of data from SEER database,
we found that the LNR was associated with poor OS and CSS in
CRC patients. Meanwhile, gender (P < 0.001), race (P < 0.001),
age (P < 0.001), tumor location (P < 0.001), pathological grade
(P < 0.001), histological type (P < 0.001), T (P < 0.001),
and M stage (P < 0.001) as well as tumor size (P < 0.001)
were considered as independent prognostic factors. We then
divided the patients into rectal cancer group and colon rectal
group according to the position of the primary tumor. The
multivariate analysis also showed that the LNR had a great
influence on patients’ survival (Supplementary Figures 2, 3,
P < 0.001). The adequate resected LNs count was taken as
a guarantee for accurate tumor staging. Therefore, we further
analyzed the impact of LNR on OS and CSS in both patients
with <12 and ≥12 resected nodes. The results were similar to
the findings of the above analyses (Supplementary Figures 4, 5,
P < 0.001).
In the analysis of our own data, the results showed that
the patient’s OS decreased when the LNR increased (Figure 3D,
P < 0.001). Multivariate analysis was also performed and
showed that the LNR still had a great influence on patients’
outcome (Supplementary Table 3, P < 0.001). In addition, we
also calculated the AIC of the models with pN or LNR and found
that the AIC was smaller in the model with LNR (2,431,814 and
1,251,010 for OS and CSS, respectively) compared with themodel
with pN (2,434,079 and 1,253,289 for OS and CSS, respectively),
indicating that the LNR may be a better prognostic factor in
comparison to pN.
TABLE 3 | Multivariate analysis of pN and clinicopathologic characteristics for
overall survival (OS) and cancer-specific survival (CSS) in SEER colorectal cancer
patients.
Characteristics Overall survival Cancer-specific survival
HR p HR p
SEX
Male vs. Female* 1.09 (1.07–1.10) <0.001 1.08 (1.06–1.10) <0.001
RACE
White Reference
Black 1.11 (1.09–1.13) <0.001 1.23 (1.20–1.26) <0.001
Other 0.78 (0.76–0.80) <0.001 0.83 (0.81–0.86) <0.001
AGE LEVEL
≥60 vs. <60* 2.71 (2.66–2.75) <0.001 1.65 (1.61–1.68) <0.001
LOCATION
Right side Reference
Left side 0.94 (0.93–0.96) <0.001 1.01 (0.99–1.03) 0.499









1.01 (0.99–1.03) 0.165 1.02 (0.99–1.04) 0.242
Signet ring cell
carcinoma
1.39 (1.31–1.47) <0.001 1.37 (1.28–1.46) <0.001
Others 1.23 (1.14–1.34) <0.001 1.41 (1.27–1.55) <0.001
T
T1 Reference
T2 1.19 (1.15–1.23) <0.001 1.52(1.42–1.62) <0.001
T3 1.54 (1.49–1.58) <0.001 2.90 (2.73–3.08) <0.001
T4 2.19 (2.12–2.26) <0.001 4.87 (4.57–5.18) <0.001
N
N0 Reference
N1 1.31 (1.29–1.33) <0.001 2.06 (2.02–2.10) <0.001
N2 1.99 (1.95–2.02) <0.001 3.41 (3.33–3.49) <0.001
M
M1 vs. M0* 3.22 (3.15–3.28) <0.001 3.56 (3.48–3.64) <0.001
SIZE LEVEL
≤2 Reference
≤3 1.07 (1.04–1.10) <0.001 1.06 (1.02–1.11) <0.001
≤5 1.10 (1.08–1.13) <0.001 1.09 (1.05–1.14) <0.001
>5 1.13 (1.10–1.16) <0.001 1.12 (1.08–1.17) <0.001
HR, hazard ratio; CI, confidence interval; *Reference category.
Five-Year OS and CSS in LNR Groups
We calculated the 5-year OS and CSS for all patients and pN1 and
pN2 patients. The results showed that patients’ survival shortened
as the LNR increased. When we examined the OS and CSS of
patients categorized as pN1, we found that the 5-year OS and
CSS rates was 62.1 and 64.8%, respectively, in patients with LNR
smaller than 0.17. While the OS and CSS rates dropped to 23.3
and 29.2% when the patients had a LNR >0.7. Furthermore,
within the pN2 group, it is not difficult to notice a huge difference
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FIGURE 3 | Kaplan-Meier cumulative survival curves of CRC patients stratified by lymph node ratio (LNR 0–4). (A) Kaplan-Meier analysis of overall survival (OS) of
CRC patients from SEER database. (B) Kaplan-Meier analysis of cancer-specific survival (CSS) of CRC patients from SEER database. (C) Cumulative probability of
CRC-specific death in competing risks. (D) Kaplan-Meier analysis of overall survival (OS) of CRC patients from international multicenter cohort.
in 5-year OS and CSS rate between patients with a LNR smaller
than 0.17 and those with a LNR >0.7 (OS: 49.3 vs. 12.8%; CSS:
55.1 vs. 15.3%). In our data, only seven patients within the pN2
group who had a LNR smaller than 0.17. We suppose that the
OS rate may be affected by the sample size and is very likely
to be inaccurate. However, the survival rate also decreased with
increasing LNR (Table 4).
DISCUSSION
In the present study, we presented a population-based analysis
of 240,898 patients in the SEER database and international
multicentre analysis of 1,878 patients in three medical centers.
Our analysis provided evidence that the cut-off values of LNR
proposed by Rosenberg et al. were well validated and led to
significant survival stratification. More importantly, compared
with the TNM staging system, the novel staging system had
stronger prognostic concordance in the present cohort. We
also demonstrated that this LNR classification had a good
performance in patients who underwent resection of <12 and
≥12 LNs. Furthermore, the LNR was found to have a similar
impact on the prognosis of patients with colon and rectal cancer.
To our knowledge, this is the largest multicentre study to assess
the value of LNR in the prediction of CRC patients’ survival.
TABLE 4 | Five-Year Survival Rates for patients with colorectal cancer stratified by
LN radio and pN category in SEER database and International multicenter.
Groups Overall(%) LNR1(%) LNR2(%) LNR3(%) LNR4(%)
5-YEAR SURVIVAL RATES BY LN RATIO (SEER)
N1 Patients
OS 49.0 62.1 41.3 31.0 23.3
CSS 57.2 64.8 49.2 37.7 29.2
N2 Patients
OS 27.1 49.3 37.0 25.2 12.8
CSS 31.2 55.1 42.2 29.2 15.3
5-YEAR SURVIVAL RATES BY LN RATIO (INTERNATIONAL MULTICENTER)
N1 Patients
OS 53.2 67.8 44.7 34.7 26.0
N2 Patients
OS 32.8 — 58.0 33.8 9.6
OS, overall survival; CSS, cancer-specific survival; LNR, lymph node radio.
It is worth mentioning that although most of the
characteristics of patients between two cohorts were statistically
significant, this result may be partly attributed to the large
sample size of the data from the SEER database. However, the
confounding factors in both cohorts were adjusted, to some
Frontiers in Oncology | www.frontiersin.org 6 December 2018 | Volume 8 | Article 628
Zhang et al. LNR Predicts the Outcome of Colrectal Cancer
extent, in the multivariate Cox regression model. Moreover,
based on the analysis, the two cohorts had similar results, further
suggesting the strong prognostic role of LNR in patients with
metastatic CRC.
It is well established that positive LN count has a strong impact
on the prognosis of CRC patients (18, 19). Hence, a thorough
LN evaluation in CRC will ensure accurate patient staging,
thus offering important information regarding the prediction
of patients’ long-term prognosis, and allow more reasonable
adjuvant chemoradiotherapy. However, the prognostic value of
pN stage is, to some extent, limited due to its relationship with
the resected LNs. Several studies demonstrated that the number
of metastatic nodes has a positive correlation with the total LN
harvested, whichwas also confirmed by our study, suggesting that
the risk of cancers with inadequate LNs may be underestimated
because of sampling error (13, 20, 21).
As a result, the AJCC and other professional organizations
recommended that a minimum of 12 nodes was required
for accurate tumor staging (22, 23). However, some pointed
out that this number had no particular biological significance;
on the contrary, it is likely a consequence of a statistical
probability distribution, suggesting that once >12 nodes have
been harvested, the likelihood of missing the remaining positive
mesenteric node becomes very small (24). Many factors may
be associated with the retrieval of the ultimate number of LNs,
including specialty of surgeon, tumor location, stage of disease,
and preoperative radiotherapy.
In an attempt to overcome these limitations, LNR, as a
significant prognostic factor, has been put forward and reported
in CRC by several studies (24–26). Nearly all studies reported
that LNR had an excellent performance in predicting patients’
survival outcome (27). However, no consensus was achieved on
the best cut-off value. On the other hand, the methods used to
calculate cut-off values varied across different studies, such as the
median value, quartiles of distribution or arbitrary values (28–
30). Only three of these groups applied statistical approaches to
stratify LNR for the discrimination of patients’ outcome. In the
first study, the cut-off value was based on SEER data from 26,186
patients and was identified 0.4 as the optimal categorization of
the LNR (20). The second study was carried out on patients with
rectal cancer, and colon cancer was not considered. In another
study, the cut-off points were 0.17, 0.41 and 0.69 with high
prognostic impact in CRC. It is not difficult to note that one
of the values mentioned above was close to 0.4; on this basis,
the researchers further optimize the stratification with another
two values. Meanwhile, both rectal cancer and colon cancer were
included in this study. That is why we finally chose these values
to be validated in our current work.
Our study found that LNR staging is superior to traditional
TNM classification in tumor staging. This conclusion is based
on the fact that the difference of 5-year OS rate between LNR1
and LNR4 in patients with pN1 is 33.8% (P < 0.001). Further
analysis has shown that 5-year OS and CSS rate of patients
in pN1 with LNR4 was much poorer than those in pN2 with
LNR1. Nevertheless, this survival difference cannot be effectively
reflected by TNM staging system. On the contrary, the survival
rates were very close when patients were in the same LNR group.
We also calculated the AIC for the model with LNR or pN
incorporated. AIC was usually used to evaluate the quality of
the model. A smaller value indicates a better model (31). In our
study, we found that AIC in themodel with LNRwas smaller than
that in the model with pN, suggesting that LNR was a superior
prognostic factor in comparison to pN. Therefore, using the LNR
as a staging system for CRC could decrease the possibility of stage
migration compared with the traditional AJCC classification
system.
It is well-known that the removal of a higher number of LNs
(>12) guarantees the accuracy for CRC staging. In other words,
pN staging may not be able to accurately predict CRC patients’
prognosis when <12 LNs are resected. As a candidate, the role
of LNR in predicting CRC patients’ survival outcome when a
lesser number of LNs are harvested remains controversial. Berger
et al. reported that the influence of the LNR on CRC patients’
survival was not significant when <10 LNs were dissected (15).
In that case, they suggested that the total number of positive
LNs was a more important factor in prognostic prediction. In
contrast, Wang et al. found that the ability of LNR in prognostic
prediction was not dependent on the number of LNs retrieved
(26). For patients with fewer than 10 LNs, the LNR remained the
most important prognostic factor. Therefore, in order to assess
the real prognostic ability of LNR in CRC patients with lower
or higher number of harvested LNs, we performed a subgroup
analysis based on the number of LN harvested (<12 vs. ≥12).
In our study conducted in 79,012 patients with examined LNs
<12, the 5-year OS and CSS rates of the patients in the high
LNR category was significantly worse than those of patients in
the low LNR category. We can see the similar trend in cases
with >12 LNs harvested. Multivariate analysis was performed to
adjust the influence of other potential factors, and results have
shown that the LNR still had a good prognostic capability when
the patients had <12 LNs dissected. Thus, the determination
of the LNR may to some extent compensate for an inadequate
number of LNs harvested in CRC surgery. Nevertheless, this
finding should be carefully viewed. An adequate number of LNs
harvested still plays an important role in the accurate assessment
of patients’ prognosis. Thus, more large-scale studies are still
needed to further confirm the value of LNR.
With regard to tumor localization, a resected colon specimen
was found to contain more LNs than a resected rectal specimen.
On the other hand, patients with rectal cancer frequently
undergo preoperative chemoradiotherapy compared with those
with colon cancer. Several studies reported that the use of
preoperative CRT was highly correlated with the smaller number
of LN harvested (32–34). Therefore, inadequate LN removal may
occur more easily in patients with rectal cancer and result in
overstaging or understaging when using pN category. To evaluate
whether LNR can be affected by the total LN yield, subgroup
analyses were performed based on the tumor location. Results
showed that LNR had similar impact on the survival outcome of
colon and rectal cancer patients.
There were some limitations in our study. Firstly, this
study was a retrospective study, and might not guarantee the
completeness of the data. For example, although the average
follow-up time of patients from the international multicentre
cohort was 9.55 years and was considered acceptable, CSS could
not be calculated because data on the cause of death was not
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available. An additional limitation was the absence of the detailed
information of adjuvant therapy in the SEER database. With this,
it would be impossible to evaluate or adjust the treatment effect.
However, patients who underwent any chemoradiotherapy were
excluded. This could reduce the bias to some extent. Moreover,
the sample size of the multicentre cohort was relatively small
compared with the SEER database. Hence, our results should be
externally validated in another large multicentre-based cohort or
population-based register.
CONCLUSION
In summary, the cut-off values of LNR by Rosenberg et al. offer
better prognostic stratification for CRC in comparison with the
number of positive LNs. The staging system that took LNR into
account may offer more survival information to patients and play
a role in treatment decisions.
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